N ERVE GROWTH FACTOR-induced gene-B (NGFI-B) was first described as an early response gene induced by NGF in the PC12 rat pheochromocytoma cells (1) and by serum growth factors in fibroblasts (2, 3). This early gene codes for a transcription factor [(4) also known as TISl in rat (5); Nur77 or NlO in mouse (6, 7); NAKl, TR3, or ST-59 in human (8-10); and xNGFI-B in xenopus (ll)] that is expressed in many tissues and cell lines in response to a wide variety of stimuli such as hormones (12), growth factors (6), ionic changes (13), and cellular stress (14) . The early and transient expression of NGFI-B leads to various cellular Inter-universitaires NGFI-B is a member of the nuclear receptor superfamily of transcription factors (18). These transcription factors bind DNA via two highly conserved zinc fingers that distinguish them from other DNA binding proteins. The DNA binding specificity of these receptors is assured by the three variable amino acids of a region of six ammo acids of the protein lying at the end of the first zinc finger and is called the P-box (18). As recently reviewed, this superfamily can be divided into four major classes based on the dimerization and the DNA binding properties of their members (19). NGFI-B is included in the fourth class of nuclear receptors. The members of this class of receptors are referred to as monomeric orphan receptors because they bind DNA as monomers (20) , and no extracellular ligands have been found to regulate their transactivation capacities (21). NGFI-B is the prototype of a subclass of monomeric orphan receptors that recognize with a high affinity the sequence AAAGGTCA called NBRE for NGFI-B responsive element (22) . The AGGTCA motif is recognized by the classical EGCKG P-box, and the upstream extension composed of two adenines is recognized by a typical seven amino acid region RRGRLPS lying at the end of the second zinc finger, which is called the A-box (20). Additionally to NGFI-B, the other members of this subclass are RNR-1 [(23) also known as NURRl for mouse (24) and NOT for 4691 human (25)] and NOR-l (26); they all share the same P-and A-boxes in their highly conserved DNA binding domains. Moreover, their carboxyl-terminal ligand binding domains show high conservation, whereas their amino-terminal activating domains are poorly conserved Thyroid cells in primary culture provide a well-documented model to study the early events involved in the proliferation and differentiation of the cell. Three major pathways are known to control growth and differentiation in dog thyrocytes in primary culture: the protein kinase C (PKC), the protein-tyrosine kinase, and the CAMP-protein kinase A (PKA) cascades. The first two cascades lead to proliferation and loss of differentiation of thyrocytes, whereas the CAMP/ PKA pathway enhances the proliferation as well as the differentiation of these cells (27) .
In this study, we first report the cloning of the dog NGFI-B complementary DNA (cDNA) from a dog thyroid cDNA library and its comparison with its counterparts from other species. We also report the study, by Northern blotting, of the differential induction and the time courses of expression of NGFI-B messenger RNA (mRNA) in dog thyrocytes in primary culture, in which the different mitogenic pathways described above were activated. Finally, we describe the results of the study, by transient transfection, of the transcriptional activity of the NGFI-B protein in this cell system. 
Ftesults
Cloning and sequencing of the dog NGFI-B cDNA
Two cDNA libraries were screened at low stringency with a rat NGFI-B cDNA probe to attempt to clone NGFI-B-related proteins from dog thyroid. The first one, referred to as ETS lh, was constructed from poly(A)+ RNAs of dog thyrocytes in primary culture stimulated 1 h with EGF, TSH, and serum. The second one, referred to as MMI/PTU, was constructed from poly(A)+ RNAs of the thyroid of a dog treated for 4 weeks with methymazol (MMI) and propylthiouracil (PTU), two agents blocking the enzymatic activity of the thyroperoxidase and thereby inhibiting the synthesis of thyroid hormones. This deprivation in seric thyroid hormones breaks up the negative feedback exerted by these hormones on the production of TSH by the pituitary and leads to a TSH hyperstimulation of the thyroid in the animal.
Clones (300,000) were screened with the rat NGFI-B cDNA probe for each library. In the first library (ETS Ih), 64 clones hybridized with the probe, and in the second one (MMI/ PTU) 20 clones were detected. Eight clones corresponding to hybridization signals of different intensities were purified and analyzed by restriction. All of them showed closely related restriction patterns. Four of these clones were partially sequenced and found to share identical sequences. The insert of the clone containing the longest cDNA sequence (2500 bp) was completely sequenced and showed an open reading frame of 1794 bp coding for a protein of 598 amino acids (Fig. 1) . The comparison of the sequence of this cDNA with the EMBL, Genbank ,and DDBJ Nucleotide Sequence Databases revealed that it was the dog counterpart of NGFI-B initially cloned in rat pheochromocytoma-derived cell line PC12 stimulated by NGF. The dog NGFI-B protein has 90.2%, 89.7%, 95.5%, and about 65% identity with its rat (4), mouse (6), human (9) and xenopus (11) equivalent, respectively. The DNA binding domain (amino acids 266-352) is the most conserved region, and the P-and the A-boxes responsible for the recognition of the NGFI-B responsive element (NBRE) are perfectly conserved. The carboxyl-terminal ligand binding domain presents a high degree of conservation, whereas the amino-terminal transactivation domain is less well conserved. Based on the frequency of its occurrence in the two screened thyroid cDNA libraries, NGFI-B seems to be a member of the NGFI-B subclass of monomeric orphan nuclear receptors present at a high level in stimulated dog thyroid.
NGFI-B mRNA regulation in dog thyrocytes in primary culture
Because the dog NGFI-B cDNA was cloned from a library constructed after stimulation of dog thyrocytes in primary culture with TSH, EGF and serum, it was of interest to determine which cascade could effectively up-regulate NGFI-B mRNA expression and with which kinetics, and whether the mRNA could be already present under basal conditions. Therefore, Northern blots were carried out using total RNA extracted from dog thyrocytes in primary culture in basal conditions and from thyrocytes treated with the different mitogenic agents TSH (1 mU/ ml), TPA (10 ng/ ml), or EGF (25 rig/ml) for various times. The levels of NGFI-B mRNA present in these different conditions were determined by hybridization of the blots with the dog NGFI-B cDNA probe. As shown in Fig. 2 , a and b (b is overexposed compared with panel a; see legend), the level of NGFI-B mRNA was undetectable in the absence of any stimulation (lanes C) and TSH, TPA, and EGF all induced a transient expression of the NGFI-B mRNA, although at very different levels and with apparent different kinetics.
TSH, which regulates both proliferation and differentiation in thyroid cells in primary culture throughout activation of the CAMP pathway (27), led to a strong induction of the NGFI-B mRNA (Fig. 2a) . The induction of NGFI-B mRNA by TSH treatment was relatively early because the mRNA was already detectable within 40 min of treatment. A maximal level of NGFI-B transcript was reached between 1-2 h after stimulation and decreased rapidly; the mRNA being barely detectable after 5 h of treatment (data not shown). Interestingly, two transcripts of different sizes (2.6 kb and 2.7 kb) were observed sequentially after stimulation. Although the larger transcript appeared first (until 1 h stimulation), the smaller one was only observed after 2 and 4 h of incubation with TSH. The kinetics of activation and the sequential appearance of the two transcripts were reproduced by 10m5 M forskolin, an adenylate cyclase activator (Fig. 2~) . The induction of the NGFI-B transcription by forskolin was not dependent on de nova protein synthesis because it was not inhibited by 10 pg/ml cycloheximide, a protein synthesis inhibitor (Fig. 2d) .
On the other hand, TPA and EGF, which both lead to proliferation but loss of differentiation of these cells (27), were responsible, respectively, of a weak and a very weak induction of NGFI-B mRNA (Fig. 2b) as compared with the TSH stimulation. Although the induction of NGFI-B expression by TPA was relatively weak compared with TSH, the kinetics of activation and the sequential appearance of the two transcripts were closely related to these induced with TSH. We observed, nevertheless, a delay of almost 0.5 h in the kinetics of appearance and disappearance of NGFI-B mRNA in the TPA condition compared with the TSH condition. The kinetics of expression of NGFI-B mRNA in the EGF condition was very different of these observed in the TSH and TPA conditions. Indeed, the appearance of NGFI-B mRNA was very early; the mRNA being detectable after 20 min of stimulation. A maximal level was reached after 40 min of induction, and this level went back quickly to its basal value. This earlier transcription of the NGFI-B gene after EGF induction compared with the induction with other agents corroborates the results described for this gene in NIH3T3 mouse fibroblastic cells (7).
The early induction and the transient expression of the NGFI-B mRNA, as well as its estimated short half-life calculated after TSH stimulation (30 min) and its de lzovo protein synthesis-independent transcription are in agreement with the results described for NGFI-B gene expression in other systems (4, 6, 41) and are typical of the behavior of the 
FIG. 1. Comparison of amino acids sequences of NGFI-B from dog (D), man (H), mouse (M), rat (R), and xenopus (X). Amino acids conserved and semi
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NGFI-B mRNA regulation in dog thyroid slices
The enhanced mRNA expression of NGFI-B by TSH was also analyzed under more physiological conditions in dog thyroid slices. As shown in Fig. 3 , the NGFI-B mRNA was detected in control thyroid slices (lane 5), whereas the levels of NGFI-B mRNA in control thyroid cells in culture (lane 1) or in freshly excised thyroid tissue from two different dogs (lanes 3 and 4) were not detectable. As for the thyroid cells in primary culture stimulated with TSH (lane 2), addition of TSH for 1 h to thyroid slices elicited a strong accumulation of the NGFI-B transcript (lane 6). Similar results have been previously published for Jun B expression in thyrocytes (42). It can be concluded that thyrocytes respond rapidly to TSH by a strong and transient increase of NGFI-B mRNA expression, even under conditions close to the in vivo situation.
Relationship between the two NGFI-B transcripts As shown above, two different sizes of the NGFI-B mRNA were sequentially observed after treatment with TSH and TPA. It has recently been established that the shortening of a poly(A) tail in short-lived mRNA may serve as a signal for triggering the decay of the mRNA body (43). This may be the case for NGFI-B, because the larger transcript disappears, whereas the levels of the smaller transcript are still increasing (Fig. 3a) , suggesting a precursor to product relationship. Therefore, the possibility that the shorter transcript might arise from the removal of a poly(A) tail from the longer transcript was analyzed by RNase H treatment of total RNA extracts, followed by Northern blotting. As shown in incubated in control culture medium or in that medium supplemented with 1 mu/ml of TSH for 1 h. Total RNA was extracted from control (C) and TSH-treated (T) cells (lanes 1 and 2, respectively), control (Cl and TSH-treated (T) thyroid slices (lanes 5 and 6, respectively), and two freshly excised dog thyroid tissues (lanes 3 and 4). Equal amounts of RNA were loaded into gel, electrophoresed, and blotted. Acridine orange staining of gel before blotting is shown. Endo. 1996 VollS7. No 11 RNase H treated Controls Total RNA obtained from a primary culture of thyrocytes incubated in the presence of 1 mu/ml TSH for the indicated times, was hybridized with oligo(dT) and treated with RNase H (see Muteri& and Methodsl The resultine RNA was electrouhoresed. in uarallel with undigested control samples, blotted and-hybridized &h NGFI-B probe. Molecular sizes of the two NGFI-B transcripts are shown in kilobases.
INDUCTION OF NGFI-B IN DOG THXROCYTES
after enzymatic treatment only the smaller transcript was present in all the lanes. This suggests that a poly(A) tail of about 0.1 kb was cleaved by RNase H, and that the two transcripts observed differed only in the size of their tails. Similar results have been reported previously in the same cell system for Jun B (42).
Study of transactivation capacity of NGFI-B in dog thyrocytes in primary culture
In parallel with the study of the mRNA level of NGFI-B in dog thyrocytes stimulated by different agents, we studied the transactivation capacity of NGFI-B in the same system by transient transfection of these cells with a reporter construction in which the transcription of the bacterial CAT reporter gene is driven by a NBRE-dependent synthetic promoter. This promoter was constructed by cloning three NGFI-B responsive elements (NBRE) upstream to the ubiquitous herpes simplex virus-thymidine kinase promoter (TK). Both, the (NBRE)aTK-CAT construction and the TK-CAT (pBLCAT5) control construction were transfected in parallel in subconfluent dog thyrocytes in primary culture by the diethvlaminoethyl-dextran method. After transfection the cells were cultured for 24 h in absence of any stimulation. The cells were then cultured for a further 24 h in the absence of any stimulating agents or in the presence of forskolin (Fo) (10 PM), EGF (25 rig/ml), or TPA (10 rig/ml), and the CAT activity was measured after preparation of cytoplasmic extracts. The results of one (out of three) representative experiment (Fig.  5) show that in the absence of any stimulation, the transcriptional activities of the TK and the (NBRE),TK promoters were weak and identical. The most important increase of the (NBRE),TK promoter transcriptional activity was observed in thyrocytes in which the intracellular CAMP pathway had been activated by forskolin. In these conditions a very slight increase of the basal transcriptional activity of the TK promoter was also detected. In the presence of TPA, a small activation of the (NBRE),TK promoter-driven transcription was observed compared with the activity of the TK promoter alone. EGF had no significant effect on the activity of the (NBRE),TK promoter nor on the basal activity of the TK promoter.
In dog thyrocytes in primary culture, the CAMP intracel- lular cascade is thus responsible for the strongest activation of the NGFI-B driven transcription, whereas TPA only poorly induces it, and EGF has apparently no effect.
Discussion
Because monomeric orphan nuclear receptors belonging to the NGFI-B subclass are described as being immediate early genes present in many cell types, we investigated the presence of members of this subclass of transcription factors in thyroid cells in which different mitogenic pathways were activated.
We first undertook the cloning of members of this subclass of nuclear receptors by screening at low stringency two cDNA libraries of stimulated dog thyrocytes using the rat NGFI-B cDNA as probe (4). Among the many positive clones, some were analyzed at random, and they all proved to correspond to the dog NGFI-B cDNA. NGFI-B seems thus to be a member of this subclass of orphan nuclear receptor present at a high level in stimulated dog thyrocytes. The amino acid sequence of the dog NGFI-B protein was compared with its counterparts from other species. As expected, the DNA binding domain containing the P-and the A-boxes was highly conserved. However, altough the carboxyl-terminal ligand binding domain also presented a high degree of conservation, the conservation in the amino-terminal transactivating domain was reduced to a few clustered motifs. The existence of such clusters of conservation, suggesting a functional role for these sequences, correlates well the localization of the transactivation domain as determined by deletion analysis of the NGFI-B protein by Paulsen et aZ. (44) . Indeed, the authors showed that the transactivation capacity of NGFI-B is principally confined into some small subdomains of the aminoterminal part of the protein.
We then studied by Northern blotting the level of NGFI-B mRNA in dog thyroid cells using the dog NGFI-B cDNA as a probe. We observed that the level of NGFI-B mRNA was barely detectable in dog thyrocytes cultured in the absence of any stimulation and also in two freshly excised dog thyroid tissue samples. Nakai et al. (8) reported the presence of NAKl (hNGFI-B) mRNA in human thyroid tissue, but a quantitative comparison of their data with our results is not possible because of technical differences between the two studies. The mitogenic agents TSH, TPA, and EGF all induced a transient expression of NGFI-B mRNA in dog thyrocytes in primary culture but at very different levels and with different kinetics. Indeed, treatment with TSH resulted in a high production of NGFI-B mRNA, whereas much lower stimulation were elicited by TPA and, specially by EGF. The fact that accumulation of NGFI-B transcripts was maximal after treatment with TSH, coupled to the observation that this response could be mimicked by treatment with forskolin, suggests that in thyrocytes, the expression of the early gene NGFI-B might be controlled primarily through the CAMP/ PKA cascade. Such an activation of NGFI-B transcription by a hormone via the cAMP/PKA pathway was already described for the adrenocortical Yl cells treated with corticotropin (ACTH) (12). Nevertheless, this privileged CAMPdependent transcription of NGFI-B seems not to be a general phenomenon as shown in C2C12 myoblastic cells (45), LS-180 colon adenocarcinoma cells (lo), and T cells (41) in which the PKC cascade has been described as being the main activation pathway promoting NGFI-B mRNA expression. The high induction of NGFI-B mRNA expression by the CAMP/ PKA cascade in thyroid cells was also demonstrated under close to in vim conditions by incubating dog thyroid slices with TSH. This result excludes a priori the possibility that the observed effect constitutes an artefact resulting from use of thyrocytes cultured as monolayers.
In fact, two closely related NGFI-B mRNAs, differing by the length of their poly(A) tails, were present during the transient expression of this gene. The longer one, present at the beginning of the induction and containing a poly(A) tail of about 100 bases was rapidly converted into a shorter one that had lost the poly(A) tail. This phenomenon, which has been described as the first step in the decay pathway for many labile mRNAs, was in agreement with the short halflife of the NGFI-B mRNA and could be caused by the presence of adenine uracil-rich elements in its 3' untranslated region as reported in many labile mRNAs (43).
To investigate whether this favored expression of NGFI-B gene transcription by the PKA pathway was still perceptible at the level of the protein and more precisely at the level of the transactivation capacity of the protein itself, we measured the transcriptional capacity of NGFI-B in the same cell system, using a reporter construction containing three copies of the NGFI-B responsive element (NBRE) in its promoter. The highest transactivation was observed after forskolin stimulation, whereas transactivation after TPA stimulation was weak, and no significant transactivation was observed after EGF stimulation. These results thus present a perfect parallelism with those obtained at the level of the amount of NGFI-B mRNA. It seems thus that if some cascade-specific postranscriptional modifications of NGFI-B do occur, such as differential phosphorylation of the protein (46), they reinforce the trend observed at the level of NGFI-B gene transcription, i.e. they concur to a more important effect of the PKA pathway (TSH/Fo) as compared with the PKC (TPA) and the mitogenic activated protein kinase (EGF) pathways.
Taken together, all these results suggest that the activation of NGFI-B could be one of the early transcriptional changes induced specifically by the CAMP / PKA pathway in thyroid cells and could thus be responsible for certain physiological effects of TSH in those cells. The effects of TSH are mainly the induction of the differentiation of the thyroid cells (27) and the induction of proliferation of those cells, a phenomenon that follows a pathway distinct from other mitogenic cascades, at least until the entrance in the cellular cycle (47). Further work will aim at defining more precisely the role of NGFI-B in these processes.
